Perrigo Seeks New Trial After $10M Patent Verdict
Perrigo Co. on Tuesday fought back against the $10.2 million jury verdict it is facing for infringing a Boston hospital's now-expired patent for the Pepcid Complete antacid, filing a flurry of...To view the full article, register now.
Already a subscriber? Click here to view full article